Market Knowledge and Stakeholder Considerations for the Biopharmaceutics Sector—Incorporating User Value and Societal Needs in Therapeutic Interventions
JavaScript is disabled for your browser. Some features of this site may not work without it.
Market Knowledge and Stakeholder Considerations for the Biopharmaceutics Sector—Incorporating User Value and Societal Needs in Therapeutic Interventions
James K. Timmis1,2*, Raymond X. Van Der Waal1, Jennifer Herz3, Mark B. Van Der Waal1, Eric Claassen1, Linda H. M. Van De Burgwal1